Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic HCV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01853254
What this trial is testing

Pegasys (Peginterferon Alfa-2a) Administered Alone or in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C Who Have Participated in Previous Pegasys Trials

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 272
Not applicableStudy completedNCT02250001
What this trial is testing

Asunaprevir/Daclatasvir Safety Surveillance in Japanese Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 2,974
Not applicableStudy completedNCT03373396
What this trial is testing

Impact of Chlordecone on Active Chronic Hepatitis

Who this might be right for
Fibrosis, Liver
Centre Hospitalier Universitaire de la Guadeloupe 283
Testing effectiveness (Phase 2)Study completedNCT00621296
What this trial is testing

Safety and Efficacy of MP-424 to Treat Chronic Hepatitis C

Who this might be right for
Hepatitis C
Tanabe Pharma Corporation 15
Testing effectiveness (Phase 2)Study completedNCT01289496
What this trial is testing

Ribavirin Dose Optimization for the Treatment of Hepatitis C

Who this might be right for
Chronic Hepatitis C
Centre hospitalier de l'Université de Montréal (CHUM) 13
Early research (Phase 1)Study completedNCT00343525
What this trial is testing

Repeat-Dose Study of Bavituximab in Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Peregrine Pharmaceuticals 24
Early research (Phase 1)Ended earlyNCT01554085
What this trial is testing

First in Human Study of ALS-002158; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C, Chronic
Alios Biopharma Inc. 78
Testing effectiveness (Phase 2)Study completedNCT01726946
What this trial is testing

Evaluate the Safety and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Vertex Pharmaceuticals Incorporated 10
Early research (Phase 1)Study completedNCT03673696
What this trial is testing

The Tolerability and Pharmacokinetics Study of HEC74647PA Capsule in Healthy Adult Subjects

Who this might be right for
Chronic Hepatitis c
Sunshine Lake Pharma Co., Ltd. 105
Testing effectiveness (Phase 2)Study completedNCT01587586
What this trial is testing

Dose Finding Study of Pegylated-P-Interferon-alpha-2b(P1101) in Treatment-Naive Subjects With Hepatitis C Virus Genotype 1 Infection

Who this might be right for
Hepatitis C, Chronic
PharmaEssentia 107
Not applicableStudy completedNCT07702396
What this trial is testing

Efficacy of 12 Weeks Versus 24 Weeks Treatment of Directly Acting Antiviral Therapy in Patients With Hepatitis C Related Chronic Liver Disease

Who this might be right for
Heptatitis C
Indus Hospital and Health Network 192
Large-scale testing (Phase 3)Study completedNCT01854697
What this trial is testing

Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) in People With Hepatitis C Virus Infection Who Have Not Had Treatment Before

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 311
Not applicableWithdrawnNCT01691235
What this trial is testing

SIMpill Medication Dispensing Device in the Treatment of HCV

Who this might be right for
Chronic Hepatitis C Virus
University of Chicago
Post-approval studies (Phase 4)Study completedNCT00545233
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) With or Without Pioglitazone in Treatment-Naive Patients With Chronic Hepatitis C and Insulin Resistance.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 155
Early research (Phase 1)Ended earlyNCT01586325
What this trial is testing

The Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of JNJ-47910382 at Different Doses and Dose Regimens in Asian Genotype-1, Chronic, HCV-Infected Patients

Who this might be right for
Chronic Hepatitis C Infection
Janssen R&D Ireland 8
Very early researchStudy completedNCT03188276
What this trial is testing

The Relationship Between MDSCs and NK Cells Activity of CHC Patient Treated by DAAs

Who this might be right for
Chronic Hepatitis C
Third Affiliated Hospital, Sun Yat-Sen University 52
Not applicableStudy completedNCT04330508
What this trial is testing

Effects of Direct-acting Antiviral Agents on HCV Cognitive Function, and Depression in HCV Related Cirrhosis: A Prospective Clinical Trial

Who this might be right for
Depression in Chronic Hepatitis C
Post Graduate Institute of Medical Education and Research, Chandigarh 385
Large-scale testing (Phase 3)Study completedNCT00039871
What this trial is testing

PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370)

Who this might be right for
HepatitisHepatitis C, ChronicFibrosis+1 more
Merck Sharp & Dohme LLC 2,333
Testing effectiveness (Phase 2)Study completedNCT00088504
What this trial is testing

Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C

Who this might be right for
Hepatitis CHepatitis
Vertex Pharmaceuticals Incorporated 315
Testing effectiveness (Phase 2)Study completedNCT01306617
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-450 With Ritonavir (ABT-450/r) When Given Together With ABT-333 and Ribavirin (RBV) in Treatment-Naïve and Non-responder Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Chronic Hepatitis C InfectionHepatitis CHepatitis C Virus
AbbVie (prior sponsor, Abbott) 50
Next Page